HealthEquity Reports First Quarter Ended April 30, 2017 Financial Results

Go back to HealthEquity Reports First Quarter Ended April 30, 2017 Financial Results

HealthEquity, Inc (HQY) PT Raised to $57 at Chardan Capital Markets; 'Strong Execution'

June 7, 2017 6:04 AM EDT

Chardan Capital Markets raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $57.00 (from $53.00) while maintaining a Buy rating.

Analyst Steven Wardell notes Q1 adj. EBITDA was in-line with expectations and a 1% topline beat driven by strong performance in the Custodial revenue.... More

HealthEquity (HQY) Tops Q1 EPS by 7c; Raises Outlook

June 6, 2017 4:10 PM EDT

HealthEquity (NASDAQ: HQY) reported Q1 EPS of $0.23, $0.07 better than the analyst estimate of $0.16. Revenue for the quarter came in at $55.4 million versus the consensus estimate of $54.77 million.

GUIDANCE:

HealthEquity sees FY2018 EPS of $0.62-$0.67, versus the consensus of $0.53. HealthEquity sees... More